Eli Lilly (LLY)Rep. Dan Newhouse (WA04) disclosed a partial sale $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

7 days

Disclosure lag

Traded

Jul 10, 2026

Disclosed

Jul 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 2, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
2. Jan 2, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
3. Mar 27, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
4. Apr 2, 2026Congress · 1 personMembers of Congress: 2 purchases
5. May 15, 2026Federal contract · $52K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $52K obligated to date
6. Jun 9, 2026FDAFDA drug approval: Ebglyss
7. Jun 10, 2026Insider · Their largest sale since 2022Officer sold ~$2.88M of LLY shares in the open market
8. Jun 10, 2026Congress · 1 personMembers of Congress: 2 purchases
9. Jul 1, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
10. Jul 10, 2026 · this disclosureCongressDisclosed partial sale of LLY — reported range $1,001 - $15,000

What came next

1. Jul 13, 2026FDAFDA drug approval: Verzenio
2. Jul 14, 2026FDAFDA drug approval: Retevmo
3. Jul 14, 2026FDAFDA drug approval: Retevmo
4. Jul 23, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.6%
5. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
6. Aug 7, 2026InsiderOfficer sold ~$5.95M of LLY shares in the open market
7. Aug 10, 2026Insider · Their largest sale since 2014Officer sold ~$2.37M of LLY shares in the open market
8. Aug 17, 2026Federal contract · $5K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $4.5K obligated to date
9. Aug 17, 2026Insider · Their largest sale since 2022Officer sold ~$7.64M of LLY shares in the open market
10. Aug 26, 2026FDAFDA drug approval: Zepbound
11. Aug 27, 2026FDAFDA drug approval: Mounjaro
12. Aug 27, 2026FDAFDA drug approval: Mounjaro
13. Sep 18, 2026FDAFDA drug approval: Inluriyo
14. Sep 18, 2026FDAFDA drug approval: Verzenio
15. Sep 23, 2026FDAFDA drug approval: Onswik
16. Sep 25, 2026FDAFDA drug approval: Olumiant

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 189 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Rep. Dan Newhouse (WA04)

• House Clerk periodic transaction report at Fidelity National Information Services (FIS)Jul 17, 2026
• House Clerk periodic transaction report at FirstEnergy (FE)Jul 17, 2026
• House Clerk periodic transaction report at FMC Corporation (FMC)Jul 17, 2026
• House Clerk periodic transaction report at Fortinet (FTNT)Jul 17, 2026
• House Clerk periodic transaction report at Honeywell (HON)Jul 17, 2026

The full history of Rep. Dan Newhouse (WA04) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Eli Lilly

• SEC Form 144Oct 7, 2026
• USAspending.gov award recordSep 1, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 25, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 13F-HRAug 18, 2026

Everything OQRO holds on this company is on its LLY page.